In this study, we presented the anti-cancer activity of Hinokiflavone through binding to the MDM2-MDMX RING domain dimer and downregulation of MDM2 and MDMX, which led to p53-dependent and independent cancer inhibition [30,38]. Here, TP53 is linked to cancer.